Saltar ao contenido
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avanzado
  • Adalimumab sustains improvemen...
  • Citar
  • Text this
  • Enviar este rexistro por email
  • Imprimir
  • Exportar rexistro
    • Exportar a RefWorks
    • Exportar a EndNoteWeb
    • Exportar a EndNote
  • Permanent link
Adalimumab sustains improvement in spinal mobility in as patients through 104 weeks - Results from atlas

Adalimumab sustains improvement in spinal mobility in as patients through 104 weeks - Results from atlas

Detalles Bibliográficos
Main Authors: Wordsworth, P, Dijkmans, B, van der Heijde, D, Davis, J, Schiff, M, Kivitz, A, Sieper, J, Mease, P, Kupper, H, Wong, R, Grp, A
Formato: Conference item
Publicado: 2008
  • Existencias
  • Descripción
  • Títulos similares
  • Staff View
Descripción
Summary:

Títulos similares

  • CLINICAL RESPONSE AND PARTIAL REMISSION SUSTAINED THROUGH 3 YEARS OF ADALIMUMAB TREATMENT IN THE ATLAS TRIAL
    por: Wordsworth, P, et al.
    Publicado: (2009)
  • Treatment with adalimumab reduces signs and symptoms and induces partial remission in patients with ankylosing spondylitis (AS): 1-year results from ATLAS.
    por: van der Heijde, D, et al.
    Publicado: (2006)
  • Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS)
    por: van der Heijde, D, et al.
    Publicado: (2008)
  • Adalimumab improves health-related quality of life in patients with active ankylosing spondylitis - The ATLAS trial.
    por: Van der Heijde, D, et al.
    Publicado: (2005)
  • Adalimumab enhances health-related quality of life in patients with active ankylosing spondylitis - Results from the atlas trial
    por: van der Heijde, D, et al.
    Publicado: (2006)

Opciones de procura

  • Historial de Procuras
  • Procura avanzada

Buscar Máis

  • Revisar o catálogo
  • Lista alfabética
  • Explore Channels
  • Reservas de curso
  • Novos exemplares

Necesita Axuda?

  • Consello de procura
  • Consulte a un Bibliotecario
  • Preguntas Frecuentes